EPA/DHA/ALA（オメガ3）の世界市場2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global EPA / DHA/ALA (Omega 3) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-12325 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、EPA/DHA/ALA（オメガ3）の世界市場を広く調査・分析し、今後の市場展望をまとめております。EPA/DHA/ALA（オメガ3）の種類別市場規模（魚油、藻油）、用途別市場規模（栄養補助食品、機能性食品・飲料、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：EPAX、Polaris、Omega Protein、Golden Omega、GC Rieber、TASA、KD Pharma、Croda、Auqi ・地域別グローバル市場分析 2015年-2020年 ・EPA/DHA/ALA（オメガ3）の北米市場（アメリカ、カナダ、メキシコ） ・EPA/DHA/ALA（オメガ3）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・EPA/DHA/ALA（オメガ3）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・EPA/DHA/ALA（オメガ3）の南米市場（ブラジル、アルゼンチン） ・EPA/DHA/ALA（オメガ3）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：魚油、藻油 ・用途別分析：栄養補助食品、機能性食品・飲料、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The EPA / DHA/ALA (Omega 3) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global EPA / DHA/ALA (Omega 3) sales will be xx in 2020 from EPA / DHA/ALA (Omega 3) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global EPA / DHA/ALA (Omega 3) market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the EPA / DHA/ALA (Omega 3) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on EPA / DHA/ALA (Omega 3) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
EPA / DHA/ALA (Omega 3) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, EPA / DHA/ALA (Omega 3) market has been segmented into
Fish Oil
Algae Oil

By Application, EPA / DHA/ALA (Omega 3) has been segmented into:
Dietary Supplements
Functional Foods & Beverages
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global EPA / DHA/ALA (Omega 3) market presented in the report. This section sheds light on the sales growth of different regional and country-level EPA / DHA/ALA (Omega 3) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global EPA / DHA/ALA (Omega 3) market.

The report offers in-depth assessment of the growth and other aspects of the EPA / DHA/ALA (Omega 3) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and EPA / DHA/ALA (Omega 3) Market Share Analysis
EPA / DHA/ALA (Omega 3) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, EPA / DHA/ALA (Omega 3) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the EPA / DHA/ALA (Omega 3) sales, revenue and market share for each player covered in this report.

The major players covered in EPA / DHA/ALA (Omega 3) are:
EPAX
Polaris
Omega Protein
Golden Omega
GC Rieber
TASA
KD Pharma
Croda
Auqi

Among other players domestic and global, EPA / DHA/ALA (Omega 3) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe EPA / DHA/ALA (Omega 3) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of EPA / DHA/ALA (Omega 3), with price, sales, revenue and global market share of EPA / DHA/ALA (Omega 3) in 2018 and 2019.
Chapter 3, the EPA / DHA/ALA (Omega 3) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EPA / DHA/ALA (Omega 3) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, EPA / DHA/ALA (Omega 3) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe EPA / DHA/ALA (Omega 3) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 EPA / DHA/ALA (Omega 3) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 Market Analysis by Application
1.3.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Overview of Global EPA / DHA/ALA (Omega 3) Market
1.4.1 Global EPA / DHA/ALA (Omega 3) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: EPA / DHA/ALA (Omega 3) Industry Impact
1.6.1 COVID-19 Potential Implications for the EPA / DHA/ALA (Omega 3)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on EPA / DHA/ALA (Omega 3)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 EPAX
2.1.1 EPAX Details
2.1.2 EPAX Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 EPAX SWOT Analysis
2.1.4 EPAX Product and Services
2.1.5 EPAX EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Polaris
2.2.1 Polaris Details
2.2.2 Polaris Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Polaris SWOT Analysis
2.2.4 Polaris Product and Services
2.2.5 Polaris EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Omega Protein
2.3.1 Omega Protein Details
2.3.2 Omega Protein Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Omega Protein SWOT Analysis
2.3.4 Omega Protein Product and Services
2.3.5 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Golden Omega
2.4.1 Golden Omega Details
2.4.2 Golden Omega Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Golden Omega SWOT Analysis
2.4.4 Golden Omega Product and Services
2.4.5 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GC Rieber
2.5.1 GC Rieber Details
2.5.2 GC Rieber Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GC Rieber SWOT Analysis
2.5.4 GC Rieber Product and Services
2.5.5 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 TASA
2.6.1 TASA Details
2.6.2 TASA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 TASA Product and Services
2.6.4 TASA EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 KD Pharma
2.7.1 KD Pharma Details
2.7.2 KD Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 KD Pharma Product and Services
2.7.4 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Croda
2.8.1 Croda Details
2.8.2 Croda Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Croda Product and Services
2.8.4 Croda EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Auqi
2.9.1 Auqi Details
2.9.2 Auqi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Auqi Product and Services
2.9.4 Auqi EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 EPA / DHA/ALA (Omega 3) Manufacturer Market Share in 2019
3.3.2 Top 6 EPA / DHA/ALA (Omega 3) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Regions
4.1.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Regions (2015-2020)
4.1.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Regions (2015-2020)
4.2 North America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.3 Europe EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.5 South America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
5.1.1 North America EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
5.1.2 North America EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
5.2 United States EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5.3 Canada EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5.4 Mexico EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
6.1.1 Europe EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
6.1.2 Europe EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
6.2 Germany EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.3 UK EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.4 France EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.5 Russia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.6 Italy EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue and Market Share by Regions (2015-2020)
7.2 China EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.3 Japan EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.4 Korea EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.5 India EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.7 Australia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
8.1.1 South America EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
8.1.2 South America EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
8.2 Brazil EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
8.3 Argentina EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.3 Turkey EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.4 Egypt EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.5 South Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Type (2015-2020)
10.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Type (2015-2020)
10.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2015-2020)
11 Global EPA / DHA/ALA (Omega 3) Market Segment by Application
11.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
11.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2015-2020)
11.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2015-2020)
12 Market Forecast
12.1 Global EPA / DHA/ALA (Omega 3) Sales, Revenue and Growth Rate (2021-2025)
12.2 EPA / DHA/ALA (Omega 3) Market Forecast by Regions (2021-2025)
12.2.1 North America EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.2 Europe EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.3 Asia-Pacific EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.4 South America EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.5 Middle East & Africa EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.3 EPA / DHA/ALA (Omega 3) Market Forecast by Type (2021-2025)
12.3.1 Global EPA / DHA/ALA (Omega 3) Sales Forecast by Type (2021-2025)
12.3.2 Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Type (2021-2025)
12.4 EPA / DHA/ALA (Omega 3) Market Forecast by Application (2021-2025)
12.4.1 Global EPA / DHA/ALA (Omega 3) Sales Forecast by Application (2021-2025)
12.4.2 Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global EPA / DHA/ALA (Omega 3) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of EPA / DHA/ALA (Omega 3) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global EPA / DHA/ALA (Omega 3) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global EPA / DHA/ALA (Omega 3) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. EPAX Basic Information, Manufacturing Base and Competitors
Table 9. EPAX EPA / DHA/ALA (Omega 3) Major Business
Table 10. EPAX EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 11. EPAX SWOT Analysis
Table 12. EPAX EPA / DHA/ALA (Omega 3) Product and Services
Table 13. EPAX EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Polaris Basic Information, Manufacturing Base and Competitors
Table 15. Polaris EPA / DHA/ALA (Omega 3) Major Business
Table 16. Polaris EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 17. Polaris SWOT Analysis
Table 18. Polaris EPA / DHA/ALA (Omega 3) Product and Services
Table 19. Polaris EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Omega Protein Basic Information, Manufacturing Base and Competitors
Table 21. Omega Protein EPA / DHA/ALA (Omega 3) Major Business
Table 22. Omega Protein EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 23. Omega Protein SWOT Analysis
Table 24. Omega Protein EPA / DHA/ALA (Omega 3) Product and Services
Table 25. Omega Protein EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Golden Omega Basic Information, Manufacturing Base and Competitors
Table 27. Golden Omega EPA / DHA/ALA (Omega 3) Major Business
Table 28. Golden Omega EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 29. Golden Omega SWOT Analysis
Table 30. Golden Omega EPA / DHA/ALA (Omega 3) Product and Services
Table 31. Golden Omega EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. GC Rieber Basic Information, Manufacturing Base and Competitors
Table 33. GC Rieber EPA / DHA/ALA (Omega 3) Major Business
Table 34. GC Rieber EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 35. GC Rieber SWOT Analysis
Table 36. GC Rieber EPA / DHA/ALA (Omega 3) Product and Services
Table 37. GC Rieber EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. TASA Basic Information, Manufacturing Base and Competitors
Table 39. TASA EPA / DHA/ALA (Omega 3) Major Business
Table 40. TASA EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 41. TASA SWOT Analysis
Table 42. TASA EPA / DHA/ALA (Omega 3) Product and Services
Table 43. TASA EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. KD Pharma Basic Information, Manufacturing Base and Competitors
Table 45. KD Pharma EPA / DHA/ALA (Omega 3) Major Business
Table 46. KD Pharma EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 47. KD Pharma SWOT Analysis
Table 48. KD Pharma EPA / DHA/ALA (Omega 3) Product and Services
Table 49. KD Pharma EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Croda Basic Information, Manufacturing Base and Competitors
Table 51. Croda EPA / DHA/ALA (Omega 3) Major Business
Table 52. Croda EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 53. Croda SWOT Analysis
Table 54. Croda EPA / DHA/ALA (Omega 3) Product and Services
Table 55. Croda EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Auqi Basic Information, Manufacturing Base and Competitors
Table 57. Auqi EPA / DHA/ALA (Omega 3) Major Business
Table 58. Auqi EPA / DHA/ALA (Omega 3) Total Revenue (USD Million) (2018-2019)
Table 59. Auqi SWOT Analysis
Table 60. Auqi EPA / DHA/ALA (Omega 3) Product and Services
Table 61. Auqi EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global EPA / DHA/ALA (Omega 3) Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global EPA / DHA/ALA (Omega 3) Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global EPA / DHA/ALA (Omega 3) Sales by Regions (2015-2020) (K Units)
Table 65. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Regions (2015-2020)
Table 66. Global EPA / DHA/ALA (Omega 3) Revenue by Regions (2015-2020) (USD Million)
Table 67. North America EPA / DHA/ALA (Omega 3) Sales by Countries (2015-2020) (K Units)
Table 68. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Countries (2015-2020)
Table 69. North America EPA / DHA/ALA (Omega 3) Revenue by Countries (2015-2020) (USD Million)
Table 70. North America EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries (2015-2020)
Table 71. Europe EPA / DHA/ALA (Omega 3) Sales by Countries (2015-2020) (K Units)
Table 72. Europe EPA / DHA/ALA (Omega 3) Sales Market Share by Countries (2015-2020)
Table 73. Europe EPA / DHA/ALA (Omega 3) Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue by Regions (2015-2020) (USD Million)
Table 77. South America EPA / DHA/ALA (Omega 3) Sales by Countries (2015-2020) (K Units)
Table 78. South America EPA / DHA/ALA (Omega 3) Sales Market Share by Countries (2015-2020)
Table 79. South America EPA / DHA/ALA (Omega 3) Revenue by Countries (2015-2020) (USD Million)
Table 80. South America EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries (2015-2020)
Table 85. Global EPA / DHA/ALA (Omega 3) Sales by Type (2015-2020) (K Units)
Table 86. Global EPA / DHA/ALA (Omega 3) Sales Share by Type (2015-2020)
Table 87. Global EPA / DHA/ALA (Omega 3) Revenue by Type (2015-2020) (USD Million)
Table 88. Global EPA / DHA/ALA (Omega 3) Revenue Share by Type (2015-2020)
Table 89. Global EPA / DHA/ALA (Omega 3) Sales by Application (2015-2020) (K Units)
Table 90. Global EPA / DHA/ALA (Omega 3) Sales Share by Application (2015-2020)
Table 91. Global EPA / DHA/ALA (Omega 3) Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Regions (2021-2025)
Table 93. Global EPA / DHA/ALA (Omega 3) Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Type (2021-2025)
Table 95. Global EPA / DHA/ALA (Omega 3) Sales Forecast by Application (2021-2025)
Table 96. Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. EPA / DHA/ALA (Omega 3) Picture
Figure 2. Global Sales Market Share of EPA / DHA/ALA (Omega 3) by Type in 2019
Figure 3. Fish Oil Picture
Figure 4. Algae Oil Picture
Figure 5. EPA / DHA/ALA (Omega 3) Sales Market Share by Application in 2018
Figure 6. Dietary Supplements Picture
Figure 7. Functional Foods & Beverages Picture
Figure 8. Others Picture
Figure 9. Global EPA / DHA/ALA (Omega 3) Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey EPA / DHA/ALA (Omega 3) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Manufacturer in 2019
Figure 30. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 EPA / DHA/ALA (Omega 3) Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 EPA / DHA/ALA (Omega 3) Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Regions (2015-2020)
Figure 37. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Regions in 2018
Figure 38. North America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
Figure 39. Europe EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
Figure 41. South America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
Figure 43. North America EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Countries (2015-2020)
Figure 45. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Countries in 2018
Figure 46. North America EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries in 2018
Figure 48. United States EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries (2015-2020)
Figure 53. Europe EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries in 2019
Figure 54. Germany EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Regions 2019
Figure 61. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue Market Share by Regions 2019
Figure 62. China EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America EPA / DHA/ALA (Omega 3) Sales Market Share by Countries in 2019
Figure 69. South America EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries in 2019
Figure 70. Brazil EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel

---